SECsense Logo

PAVmed Inc. 8-K Report: Stock Insights & Financial Maneuvers as of January 2025

$PAVM
Form 8-K
Filed on: 2025-01-15
Source
PAVmed Inc. 8-K Report: Stock Insights & Financial Maneuvers as of January 2025

Here is the extracted key information and insights from the provided financial report section:

  1. Entity Information:
  • Company Name: PAVmed Inc.
  • CIK Number: 0001624326
  • SEC Filing Type: 8-K
  • Filing Date: January 15, 2025
  • Address: 360 Madison Avenue, 25th Floor, New York, NY 10017
  • Contact Number: (917) 813-1828
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.01 per share
    • Ticker Symbol: PAVM
    • Exchange: NASDAQ
  • Series Z Warrants:
    • Ticker Symbol: PAVMZ
    • Type: Warrants to purchase common stock
  1. Issuance Context:
  • The report references specific contexts and segments, indicating different classes of stock and warrants. The common stock and Series Z warrants are both being reported as of January 15, 2025.
  1. Financial Period:
  • The report details a financial snapshot as of January 15, 2025, which suggests the information pertains to a specific reporting date without a continuous range.
  1. Units of Measurement:
  • The report utilizes USD as the currency and shares as the unit of measurement for stock-related entries.
  1. Insights:
  • The filing indicates ongoing activities related to stock and warrants, which could imply corporate actions such as fundraising, stock issuance, or other strategic initiatives.
  • The presence of Series Z warrants suggests that the company may be using these instruments as a means to raise capital or incentivize investment.

Overall, this segment provides a concise overview of PAVmed Inc.'s stock structure and recent SEC filing, indicating potential financial maneuvers and the company's operational context as of early 2025.